Nanjing Leads Biolabs Co.,ltd

This early-phase study tested a new drug called LBL-007 combined with toripalimab (and sometimes axitinib) in 79 people with advanced melanoma that could not be removed by surgery or had spread. The main goals were to check safety, find the best dose, and see if tumors shrink. Pa…

This study tested a new drug called LBL-019, given alone or with another cancer drug, in 26 adults with advanced cancers that had stopped responding to standard treatments. The main goals were to check safety and how well the drug works at controlling tumor growth. This is an ear…

This study tested a combination of two experimental drugs, LBL-007 and tislelizumab, in 98 adults with advanced solid tumors. The main goals were to find safe doses and see if the drugs could shrink tumors. The trial was completed and focused on safety and early signs of effectiv…